Biocorp will be exhibiting at 2017 edition of Pharmapack Europe 1st & 2nd February.
BIOCORP will display its innovations in the field of connected devices and pharmaceutical devices, and present its manufacturing activities (injection molding, assembly, packaging).
Eric Dessertenne, Chief Operating Officer, will give a presentation at The Conference Session 2 on “Patient adherence: new challenges, new opportunities”, Wednesday 1st at 2.40 PM. He will explain how connected devices can not only monitor treatment adherence but also guarantee better and safer treatment administration.
BIOCORP will also participate to the Innovation Gallery, introducing NEWGUARD, a new generation integrated passive safety device compatible with various sizes of stacked needles PFS. This innovative solution creates new benefits for pharmaceutical companies in terms of supply chain, TCO and packaging. NEWGUARD meets both the economic criteria and the end users’ protection requirements.
